Liquid Chromatography with Tandem Mass Spectrometric Method for Determination of 52 Antibiotics in Human Whole Blood and Urine and Application to Forensic Cases

Overview

Journal Forensic Toxicol

Specialties Forensic Sciences
Toxicology

Date 2024 Apr 20

PMID 38642241

Authors

Qianwen Shi

Gege Wang

Shuhui Wang

Chao Zhang

Zhiwen Wei

Zhongyuan Guo

Dan Zhang

Keming Yun

Shanlin Fu

Affiliations

Soon will be listed here.

Abstract

Purpose: A rapid and reliable method was developed and validated for the simultaneous analysis of 52 antibiotics (cephalosporins, penicillins, carbapenems, lincosamides, quinolones, nitroimidazoles, macrolides, sulfonamides, tetracyclines, glycopeptide) in urine and whole blood by high-performance liquid chromatography-tandem mass spectrometry (HPLC-MS/MS).

Method: Analytes were extracted by dilution or protein precipitation and analyzed on an Agilent 1260 HPLC system coupled to an Agilent 6470 Triple Quadrupole Mass Spectrometer.

Results: The method attended method validation criteria. The limits of detection were equal or lower than 2.0 ng/mL, whereas the limits of quantification ranged from 0.1 to 10.0 ng/mL, from 0.1 to 5.0 ng/mL, in urine and whole blood, respectively. For all analytes, the bias and intra- and inter-day precision values were less than 14.7%. The ranges of recovery values of all antibiotics were 76.5-124.5% in whole blood and 76.3-121.8% in urine, values of the effects were lower than 25% in two matrices. No evidence of carryover was observed. The study of sample stability showed that almost all analytes were stable at 24 °C for 24 h, all analytes were stable at -20 °C for 14 days and at -80 °C for 30 days. Freeze-thaw cycles stability showed that antibiotics were stable except for imipenem. Autosampler stability study showed that all analytes were stable for 24 h, except for imipenem and amoxicillin. Applicability was proven by analyzing authentic whole blood (n = 86) and urine (n = 79) samples from patients under antibiotics treatment. Therefore, this method was applied to the analysis 3 forensic allergy cases, which were positive for at least one analyte.

Conclusions: A simple, sensitive and high-throughput method for the simultaneous determination of different classes of antibiotics in urine and whole blood samples was developed and applied. This sensitive method was successfully applied to forensic cases.

References

Turner P, Campbell D, Motosue M, Campbell R . Global Trends in Anaphylaxis Epidemiology and Clinical Implications. J Allergy Clin Immunol Pract. 2019; 8(4):1169-1176. PMC: 7152797. DOI: 10.1016/j.jaip.2019.11.027. View

Mullins R, Wainstein B, Barnes E, Liew W, Campbell D . Increases in anaphylaxis fatalities in Australia from 1997 to 2013. Clin Exp Allergy. 2016; 46(8):1099-110. DOI: 10.1111/cea.12748. View

Yu R, Krantz M, Phillips E, Stone Jr C . Emerging Causes of Drug-Induced Anaphylaxis: A Review of Anaphylaxis-Associated Reports in the FDA Adverse Event Reporting System (FAERS). J Allergy Clin Immunol Pract. 2020; 9(2):819-829.e2. PMC: 7870524. DOI: 10.1016/j.jaip.2020.09.021. View

Tanno L, Bierrenbach A, Calderon M, Sheikh A, Simons F, Demoly P . Decreasing the undernotification of anaphylaxis deaths in Brazil through the International Classification of Diseases (ICD)-11 revision. Allergy. 2016; 72(1):120-125. DOI: 10.1111/all.13006. View

Ma L, Danoff T, Borish L . Case fatality and population mortality associated with anaphylaxis in the United States. J Allergy Clin Immunol. 2013; 133(4):1075-83. PMC: 3972293. DOI: 10.1016/j.jaci.2013.10.029. View

Pumphrey R, Roberts I . Postmortem findings after fatal anaphylactic reactions. J Clin Pathol. 2000; 53(4):273-6. PMC: 1731177. DOI: 10.1136/jcp.53.4.273. View

Low I, Stables S . Anaphylactic deaths in Auckland, New Zealand: a review of coronial autopsies from 1985 to 2005. Pathology. 2006; 38(4):328-32. DOI: 10.1080/00313020600820831. View

Greenberger P, Rotskoff B, Lifschultz B . Fatal anaphylaxis: postmortem findings and associated comorbid diseases. Ann Allergy Asthma Immunol. 2007; 98(3):252-7. DOI: 10.1016/S1081-1206(10)60714-4. View

Breier A, Garcia C, Oppe T, Steppe M, Schapoval E . Microbiological assay for azithromycin in pharmaceutical formulations. J Pharm Biomed Anal. 2002; 29(5):957-61. DOI: 10.1016/s0731-7085(02)00213-3. View

10.

Zhao C, Pan B, Wang M, Si Y, Taha A, Liu G . Improving the Sensitivity of Nanofibrous Membrane-Based ELISA for On-Site Antibiotics Detection. ACS Sens. 2022; 7(5):1458-1466. DOI: 10.1021/acssensors.2c00208. View

11.

Magreault S, Jaureguy F, Zahar J, Mechai F, Toinon D, Cohen Y . Automated HPLC-MS/MS assay for the simultaneous determination of ten plasma antibiotic concentrations. J Chromatogr B Analyt Technol Biomed Life Sci. 2022; 1211:123496. DOI: 10.1016/j.jchromb.2022.123496. View

12.

Wang X, Guo T, Wei Y, Xu G, Li N, Feng J . Determination of Quinolone Antibiotic Residues in Human Serum and Urine Using High-Performance Liquid Chromatography/Tandem Mass Spectrometry. J Anal Toxicol. 2019; 43(7):579-586. DOI: 10.1093/jat/bkz034. View

13.

Lefeuvre S, Bois-Maublanc J, Hocqueloux L, Bret L, Francia T, Eleout-Da Violante C . A simple ultra-high-performance liquid chromatography-high resolution mass spectrometry assay for the simultaneous quantification of 15 antibiotics in plasma. J Chromatogr B Analyt Technol Biomed Life Sci. 2017; 1065-1066:50-58. DOI: 10.1016/j.jchromb.2017.09.014. View

14.

Feliu C, Konecki C, Candau T, Vautier D, Haudecoeur C, Gozalo C . Quantification of 15 Antibiotics Widely Used in the Critical Care Unit with a LC-MS/MS System: An Easy Method to Perform a Daily Therapeutic Drug Monitoring. Pharmaceuticals (Basel). 2021; 14(12). PMC: 8703964. DOI: 10.3390/ph14121214. View

15.

Sun H, Xing H, Tian X, Zhang X, Yang J, Wang P . UPLC-MS/MS Method for Simultaneous Determination of 14 Antimicrobials in Human Plasma and Cerebrospinal Fluid: Application to Therapeutic Drug Monitoring. J Anal Methods Chem. 2022; 2022:7048605. PMC: 8754666. DOI: 10.1155/2022/7048605. View

16.

Decosterd L, Mercier T, Ternon B, Cruchon S, Guignard N, Lahrichi S . Validation and clinical application of a multiplex high performance liquid chromatography - tandem mass spectrometry assay for the monitoring of plasma concentrations of 12 antibiotics in patients with severe bacterial infections. J Chromatogr B Analyt Technol Biomed Life Sci. 2020; 1157:122160. DOI: 10.1016/j.jchromb.2020.122160. View

17.

Lu W, Pan M, Ke H, Liang J, Liang W, Yu P . An LC-MS/MS method for the simultaneous determination of 18 antibacterial drugs in human plasma and its application in therapeutic drug monitoring. Front Pharmacol. 2022; 13:1044234. PMC: 9679284. DOI: 10.3389/fphar.2022.1044234. View

18.

Huo J, Guo Y, Zhang B, Zhao Z, Shi G, Mei S . A UHPLC-MS/MS method for the simultaneous determination of vancomycin, norvancomycin, meropenem, and moxalactam in human plasma and its clinical application. J Mass Spectrom. 2023; 58(6):e4925. DOI: 10.1002/jms.4925. View

19.

Duan X, Zhang Y, Yan J, Zhou Y, Li G, Feng X . Progress in Pretreatment and Analysis of Cephalosporins: An Update Since 2005. Crit Rev Anal Chem. 2019; 51(1):55-86. DOI: 10.1080/10408347.2019.1676194. View

20.

Dailly E, Bouquie R, Deslandes G, Jolliet P, Le Floch R . A liquid chromatography assay for a quantification of doripenem, ertapenem, imipenem, meropenem concentrations in human plasma: application to a clinical pharmacokinetic study. J Chromatogr B Analyt Technol Biomed Life Sci. 2011; 879(15-16):1137-42. DOI: 10.1016/j.jchromb.2011.03.038. View